Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 21:55:34 GMT 2025
by
admin
on
Mon Mar 31 21:55:34 GMT 2025
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
P050J5FWC5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
L03AB03
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
||
|
FDA ORPHAN DRUG |
354711
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
||
|
FDA ORPHAN DRUG |
246107
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
||
|
WHO-VATC |
QL03AB03
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
||
|
LIVERTOX |
NBK548199
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/05/281
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5570
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
PRIMARY | |||
|
P-01579
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
PRIMARY | |||
|
5570
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
PRIMARY | |||
|
SUB14223MIG
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
PRIMARY | |||
|
100000089508
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
PRIMARY | |||
|
P050J5FWC5
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
PRIMARY | |||
|
INTERFERON GAMMA
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
PRIMARY | |||
|
m6306
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID6037647
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
PRIMARY | |||
|
82115-62-6
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
PRIMARY | |||
|
C583
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
PRIMARY | |||
|
P050J5FWC5
Created by
admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
|
PRIMARY |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_25 |
| N | 1_97 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT MAY BE PRESENT |
T lymphocytes secrete interferon gamma (IFN-?) and IL-2 following co-culture with BCMA-expressing cells
|
||
|
PARENT -> CONSTITUENT MAY BE PRESENT |
secrete interferon gamma in esponse to CD22 expressing tumour cell lines
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
|
ACTIVATOR OF EXPRESSION->TARGET |
|
||
|
INHIBITOR OF EXPRESSION->TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
T-CELLS->EXPRESSED PROTEIN |
upon activation
|
||
|
INHIBITOR OF EXPRESSION->TARGET |
|
||
|
INHIBITOR OF EXPRESSION->TARGET |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
The T lymphocytes secrete interferon gamma (IFN-?)
following co-culture with BCMA-expressing cells
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
ACTIVATOR OF EXPRESSION->TARGET |
when co-cultured with CD70 expressing cell
IN-VITRO
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO_ACID_SUBSTITUTION | [1_1] | Gln |
Amount:
|
PIDOLIC ACID | SZB83O1W42 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|